Summary
This prediction ended on 06.12.17 with a price of €104.50. With a performance of -6.45%, the BUY prediction for Bayer AG by Subdi closed slightly in the red. Subdi has 50% into this predictionBayer is a multinational pharmaceutical and life sciences company headquartered in Germany. The company was founded in 1863 and has since grown to become a global leader in the fields of pharmaceuticals, agriculture, and consumer health. Bayer is listed on the Frankfurt Stock Exchange and also trades over-the-counter in the United States under the ticker symbol BAYZF. The company's products include prescription drugs, over-the-counter medicines, and agrochemicals, and it operates in more than 90 countries around the world.
Performance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Bayer AG | 4.980% | 4.980% | 110.487% | -22.068% |
| iShares Core DAX® | -1.673% | 2.237% | 16.344% | 61.776% |
| iShares Nasdaq 100 | -1.346% | 0.290% | 3.851% | 105.171% |
| iShares Nikkei 225® | -1.529% | 5.863% | 18.286% | 52.222% |
| iShares S&P 500 | -1.702% | 0.697% | 1.755% | 66.580% |
Comments by Subdi for this prediction
In the thread Bayer AG diskutieren
Subdi stimmt der Buy-Einschätzung von Subdi zu
Subdi stimmt am 27.10.2017 der Buy-Einschätzung von Subdi mit dem Kursziel 128€ zu.Überschrift: Subdi stimmt der Buy-Einschätzung von DirectorDealer_Intensive zu
(Vom Mitglied beendet)